English | Español
Erianne Leatherman | Jun 6, 2017

Zykadia under consideration in Europe for expanded use to treat non-small cell lung cancer
Carrice Quinnie | Jun 4, 2017

Merck enters exclusive license agreement with Teijin Pharma
Robert Hadley | Jun 4, 2017

AstraZeneca to reveal results of three cancer-fighting drugs at ASCO meeting
Robert Hadley | Jun 4, 2017

Merck’s targeted tumor drug approved for colorectal and other cancers
Robert Hadley | Jun 3, 2017

FDA OKs Novartis' Zykadia for metastatic lung cancer affecting the brain
Robert Hadley | Jun 2, 2017

FDA approves higher once-a-day dose of Merck’s Isentress HIV drug 
Tabitha Fleming | Jun 2, 2017

Merck's Keytruda approved for treating Hodgkin's lymphoma in Europe
Robert Hadley | May 31, 2017

FDA greenlights review of Bristol-Myers Squibb’s Opdivo for liver cancer

Trending
Patient Daily | Jul 8, 2025

Clinical assistant professor at Stanford: ‘Musical background is associated with better performance of fundamental surgical skills'
+ Pharmaceuticals
Patient Daily | Jul 8, 2025

Psychedelic mushrooms' compound shows potential antiaging effects
Patient Daily | Jul 9, 2025

FDA approves Longeveron's Phase 2 study for pediatric dilated cardiomyopathy treatment